As part of the agreement, EchelonDx is providing expertise using its precise PrenatalDx technology to help enhance the data analysis and reporting capabilities for Cradle’s comprehensive fetal genetic analysis and health screening solutions.
Read More
Myriad Genetics has entered into a definitive agreement to sell select operating assets and intellectual property, including the Vectra test, from Myriad Autoimmune’s business unit to Labcorp for $150 million in cash.
Read More
New findings from Rockefeller University suggest that so-called breakthrough cases may be driven by rapid evolution of the virus, and that ongoing covid-19 testing of immunized individuals will be important to help mitigate future outbreaks.
Read More
Mass-Fix has been recognized by the International Myeloma Working Group as an alternative to immunofixation, and is now recommended for diagnosing and monitoring patients with monoclonal protein disorders.
Read More
Researchers say the pinprick method accurately measures in under one hour the concentration of coronavirus antibodies in blood.
Read More